Professor Jin-Kuk Kim of the Graduate School of Medical Science and Engineering at KAIST received the ‘Paper of the Year Award’ from the Oligonucleotide Therapeutics Society, an international conference in the field of ribonucleic acid (RNA)-based therapy.


Professor Jin-Kuk Kim is sharing his thoughts after receiving the 'Paper of the Year Award' in Barcelona, Spain. Photo by KAIST

Professor Jin-Kuk Kim is sharing his thoughts after receiving the 'Paper of the Year Award' in Barcelona, Spain. Photo by KAIST

View original image

According to KAIST on the 26th, Professor Kim received the Paper of the Year Award at the annual meeting held the previous day in Barcelona, Spain.


The Oligonucleotide Therapeutics Society is regarded as the most prestigious society in RNA-based therapy and holds its annual meetings alternately in Europe and the United States.


The Paper of the Year Award is given to one corresponding author each in two categories?one in basic research and one in clinical translation?selected from RNA-based therapeutic development research papers published in the past year.


Professor Kim’s paper was selected as the Paper of the Year in the clinical translation category.


Professor Kim recently developed patient-customized therapeutics for rare genetic diseases and established guidelines to expand their application to a larger patient population, publishing the paper in the international journal Nature last July.



This research was conducted jointly with Professor Timothy Yu’s team at Harvard Medical School, supported by the Ministry of Science and ICT’s Brain Pool Plus program for attracting outstanding foreign scientists, with KAIST Graduate School of Medical Science and Engineering doctoral candidate Si-Jae Woo participating as the first author.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing